Mohammad H Farzaei
Overview
Explore the profile of Mohammad H Farzaei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fakhri S, Kiani A, Jalili C, Abbaszadeh F, Piri S, Farzaei M, et al.
Curr Mol Pharmacol
. 2020 Dec;
14(4):646-657.
PMID: 33380311
Background: Spinal cord injury (SCI), often characterized by sensory-motor dysfunction, is a major debilitating disorder of the central nervous system. As no useful treatment for post- SCI complications has been...
2.
Rahimi R, Nikfar S, Sadeghi M, Abdollahi M, Moghaddam R, Farzaei M
Curr Pharm Biotechnol
. 2020 Dec;
22(11):1511-1519.
PMID: 33308129
Background: It has been found that there is a link between hypertension and elevated risk of Alzheimer's Disease (AD). Herein, a meta-analysis based on Randomized Clinical Trials (RCTs) was used...
3.
Fakhri S, Patra J, Das S, Das G, Majnooni M, Farzaei M
Curr Mol Pharmacol
. 2020 Dec;
14(6):943-959.
PMID: 33297926
Background: As a major cause of morbidity and mortality, cardiovascular diseases (CVDs) are globally increasing. In spite of recent development in the management of cardiovascular complications, CVDs have remained a...
4.
Khazaei H, Pesce M, Patruno A, Aneva I, Farzaei M
Phytother Res
. 2020 Oct;
35(4):1697-1718.
PMID: 33079410
Diabetes mellitus is a metabolic defect with many complications for the patients. Deaths due to diabetes and its complications are increasing, and one of the most serious consequences are the...
5.
Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei M, Nabavi S
Curr Pharm Biotechnol
. 2019 Dec;
21(13):1342-1353.
PMID: 31840607
An increase in the prevalence of Inflammatory Bowel Diseases (IBD) as a multifactorial intestinal chronic inflammation as well as the absence of a certain cure, has created an innovative era...
6.
Joshi T, Singh A, Haratipour P, Sah A, Pandey A, Naseri R, et al.
J Cell Physiol
. 2019 Mar;
234(10):17212-17231.
PMID: 30916407
Diabetes affects a large population of the world. Lifestyle, obesity, dietary habits, and genetic factors contribute to this metabolic disease. A target pathway to control diabetes is the 5'-adenosine monophosphate-activated...
7.
Dolatabadi F, Abdolghaffari A, Farzaei M, Baeeri M, Ziarani F, Eslami M, et al.
J Neurogastroenterol Motil
. 2018 Jun;
24(3):490-501.
PMID: 29879761
Background/aims: The aim of present study is to estimate the effects of L. (MO) on visceral hypersensitivity (VH), defecation pattern and biochemical factors in 2 experimental models of irritable bowel...
8.
Zobeiri M, Belwal T, Parvizi F, Naseri R, Farzaei M, Nabavi S, et al.
Curr Pharm Biotechnol
. 2018 May;
19(3):196-205.
PMID: 29766801
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease mainly caused by high-fat diets and sudden feed changes, vitamin and energy deficiency, and inflammatory processes. Fatty...
9.
Farzaei M, Bahramsoltani R, Abdollahi M, Rahimi R
J Neurogastroenterol Motil
. 2016 Jul;
22(4):558-574.
PMID: 27431236
Irritable bowel syndrome (IBS) is the most common disorder referred to gastroenterologists and is characterized by altered bowel habits, abdominal pain, and bloating. Visceral hypersensitivity (VH) is a multifactorial process...
10.
Farzaei M, Rahimi R, Abdollahi M
Curr Pharm Biotechnol
. 2015 Jan;
16(3):196-210.
PMID: 25601607
Inflammatory bowel disease (IBD) is an idiopathic chronic, relapsing inflammation of the bowel which is caused by dysregulation of the mucosal immune system. Polyphenols as the secondary plant metabolites universally...